Stern, M.B.

Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease

Weintraub, D., Mavandadi, S., Mamikonyan, E., Siderowf, A. D., Duda, J. E., Hurtig, H. I., Colcher, A., Horn, S. S., Nazem, S., Ten Have, T. R., et al. (2010) · Neurology

Parkinson's Disease Mechanisms and TreatmentsTreatment of Major Depression

Cited by 255

Apolipoprotein E controls the risk and age at onset of Parkinson disease

Li, Y. J., Hauser, M. A., Scott, W. K., Martin, E. R., Booze, M. W., Qin, X. J., Walter, J. W., Nance, M. A., Hubble, J. P., Koller, W. C., et al. (2004) · Neurology

Parkinson's Disease Mechanisms and TreatmentsAlzheimer's disease research and treatments

Cited by 144